The Proteasome Inhibitor, Bortezomib, Sensitizes Tumors to Adherent Lymphokine Activated Killer (ALAK)-Cell Mediated Attack
William H.D. Hallett, Isabel Barao, Thomas J. Sayers, William J. Murphy
Related File(s): - Hallett.pdf
Size/Type: 17.54 KB (application/pdf)
This item was last modified on: -0/1-/2005
|
